Back to Markets
View all Q&A →
Stocks● Neutral
Pro Medicus shares slip 5.8% as healthcare IT draws buyers
Pro Medicus shares are down 5.8% in 2025. The healthcare imaging software provider relies on subscription revenue and U.S. hospital contracts. Half-year results are due in February.
Continue with
Pro Medicus shares have fallen 5.8% since the start of 2025. The company, founded in 1989, builds medical imaging software used by hospitals and radiology clinics. It sells subscriptions, which produce recurring revenue.
Healthcare IT companies have benefited from hospital spending on digital tools. Pro Medicus has won large contracts in the U.S., including an agreement with the Department of Veterans Affairs. That contract helped drive a 40% share price gain in 2024.
The recent decline brings Pro Medicus's market value to roughly A$8 billion. The company has not announced any new contracts so far in 2025. Its half-year financial results are due in February. The company has not provided guidance for the full year.
How this story was producedLast reviewed Jul 3, 2026
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.
Explore More
More from AlphaScala
Stocks
How a Python Project Rewired One Developer's Thinking
Jul 3
StocksHypercharge CEO Gets 1M Options at $0.11 to Replace Expired Grant
Jul 3
StocksSpeed Up by Slowing Down: A Trader's Cognitive Edge
Jul 3
StocksZEN.COM Adds Mastercard Click to Pay Across 33 Markets
Jul 3
StocksOne Japanese Town's 2.95 Birth Rate Defies National Slide
Jul 3
StocksIndonesia's 54,716 km coastline: second-longest globally, behind Canada
Jul 3
Trading Q&A
How to start trading stocks as a beginner?
What is the S&P 500 index?
What is an ETF and how does it work?
What is a hedge fund?